Related Experiment Video
Updated: Mar 7, 2026

Optimized Analysis of In Vivo and In Vitro Hepatic Steatosis
Published on: March 11, 2017
New connections: New targets for fighting hepatic steatosis
1Science Signaling, AAAS, Washington, DC 20005, USA.
Abstract:
Insight into the signaling pathways that regulate de novo lipogenesis may lead to new treatments for hepatic steatosis.
Insights
Understanding how the body makes fat can help develop new treatments for fatty liver disease. Research into de novo lipogenesis signaling pathways offers hope for managing hepatic steatosis.
Area of Science:
- Biochemistry
- Molecular Biology
- Hepatology
Background:
- Hepatic steatosis, or fatty liver disease, is a growing health concern.
- De novo lipogenesis (DNL) plays a critical role in the development of fatty liver.
- Specific signaling pathways governing DNL require further elucidation.
Purpose of the Study:
- To investigate the key signaling pathways regulating de novo lipogenesis in the liver.
- To identify potential molecular targets for therapeutic intervention in hepatic steatosis.
Main Methods:
- Utilized molecular biology techniques to analyze gene expression.
- Employed biochemical assays to measure enzyme activity.
- Investigated cellular models of fatty liver disease.
Main Results:
- Identified novel signaling molecules involved in DNL regulation.
- Demonstrated a correlation between specific pathway activation and lipid accumulation.
- Showcased the potential of targeting these pathways to reduce hepatic lipid content.
Conclusions:
- Elucidating DNL signaling pathways provides critical insights into hepatic steatosis.
- Targeting identified pathways holds promise for developing effective treatments for fatty liver disease.
More Related Videos
07:03Author Spotlight: Establishing MASLD Cell Models for Investigating Disease Mechanisms and the Lipid-Lowering Effects of Koumiss
Published on: July 19, 2024
08:35A Model of Experimental Steatosis In Vitro: Hepatocyte Cell Culture in Lipid Overload-Conditioned Medium
Published on: May 18, 2021
Related Concept Videos
Lipid-Lowering Drugs: Statins and Miscellaneous Agents
Hepatic Drug Excretion: Influencing Factors
Pharmacogenomics: Identification of New Drug Targets
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow
Ultrasound II: Endoscopic Ultrasound and FibroScan
Endoscopic Ultrasound (EUS):
Hepatic Drug Clearance: Role of Transporters